Friday, February 17, 2017 12:21:50 PM
The discussions here about the blue dye are worthless imho. The most important factor of Rexista is NOT the blue dye but the nPODDDS technology, leading to a shift in the drug release and by that reducing the tampering to misuse. THAT is the key differentiator!!
Furthermore even if the FDA has concerns about the blue dye (what would be surprising after successfull Phase I trials and the intense dialogue) they might approve it with certain restrictions.
Finally:
1. We are valued at $71,5 million.
2. Nearly no debt.
3. Cash at least until June.
4. Rising revenues - maybe break even in Q4 (even without Rexista!).
5. Further ANDA approvals highly likely
And not to forget: a potential revolutionary technology with PODRAS and a further product candidate ready for partnering (Regabatin) with a market potential of 4.2 billion! PLUS Rexista = potential best in class Ocycontin and parterning discussions ongoing.
So please use your mind and keep your emotions under control. The ones arguing here against IPCI repeat the same points again and again. But that are distractions. Yes we have Odidis loan with an interest of 12.5%, yes there might be a risk of Purdue suing and yes, maybe there is a potential risk in the blue dye - so what? Tell me something new! And especially something that is not already priced into the current tiny valuation. Even start ups with no business at all reach multiple valuations of IPCIs.
So, here I stand in the rain, hearing the laughter of the bears and seeing my investment losing book value. BUT I'M STILL STANDING! And I will also in the near future, when IPCI finally starts its journey to a total revaluation, when the laughter will end and the bulls will be stronger than ever.
Best regards to all!
cysonic
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM